RAPT

RAPT Therapeutics, Inc.

3.15 USD
+0.06 (+1.94%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

RAPT Therapeutics, Inc. stock is down -31.97% since 30 days ago. The next earnings date is Aug 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 10 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
24 Apr 19:50 16 Aug, 2024 22.50 PUT 29 2500
24 Apr 19:50 16 Aug, 2024 22.50 PUT 60 2500
24 Apr 19:50 16 Aug, 2024 22.50 PUT 29 2500
24 Apr 19:50 17 May, 2024 17.50 PUT 29 2086
24 Apr 19:50 17 May, 2024 17.50 PUT 29 2086
29 Apr 17:01 16 Aug, 2024 7.50 PUT 250 7345
09 May 13:33 16 Aug, 2024 15.00 PUT 75 94
09 May 14:12 21 Jun, 2024 7.50 PUT 132 326
21 May 15:41 16 Aug, 2024 7.50 PUT 81 7700
21 May 15:41 16 Aug, 2024 7.50 PUT 70 7700

About RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc. focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues.